Differences

This shows you the differences between two versions of the page.

Link to this comparison view

geri:dementia:corticobasal-degeneration-cbd [on June 2, 2019]
geri:dementia:corticobasal-degeneration-cbd [on June 2, 2019]
Line 2: Line 2:
 {{INLINETOC}} {{INLINETOC}}
 ===== Primer ===== ===== Primer =====
-**Corticobasal Degeneration** (CBD) is an neurodegenerative disorder, classified as an atypical parkinsonian syndrome (also known as Parkinson'​s ​Plus). CBD was previously classified as a progressive asymmetric movement disorder characterized by akinesia, rigidity, dystonia, focal myoclonus, ideomotor apraxia, and/or alien-limb phenomena. However, it is increasingly seen as a disorder with cognitive and behavioural disturbances as well. The diagnosis of CBD remain challenging because there is considerable overlap between CBD pathology and other neurodegenerative disorders ​(including [[geri:​dementia:​progressive-supranuclear-palsy-psp|progressive supranuclear palsy]] (PSP), [[geri:​dementia:​alzheimers|]],​ and [[geri:​dementia:​frontotemporal|frontotemporal dementia]]).+**Corticobasal Degeneration** (CBD) is an neurodegenerative disorder, classified as an atypical parkinsonian syndrome (also known as one of the Parkinson'​s-plus syndromes). CBD was previously classified as a progressive asymmetric movement disorder characterized by akinesia, rigidity, dystonia, focal myoclonus, ideomotor apraxia, and/or alien-limb phenomena. However, it is increasingly seen as a disorder with cognitive and behavioural disturbances as well. The diagnosis of CBD remain challenging because there is considerable overlap between CBD pathology and other neurodegenerative disorders including [[geri:​dementia:​progressive-supranuclear-palsy-psp|progressive supranuclear palsy]] (PSP), [[geri:​dementia:​alzheimers|]],​ and [[geri:​dementia:​frontotemporal|frontotemporal dementia]].
  
 ===== Diagnostic Criteria ===== ===== Diagnostic Criteria =====